article thumbnail

AI Measures Fat Around the Heart, a Key to Predicting Heart Attacks

DAIC

2 An estimated 10% of patients with PAOD have its most severe form: chronic limb-threatening ischemia (CLTI). Determinants of long-term outcomes and costs in the management of critical limb ischemia: A population-based cohort study. J Am Heart Assoc. Eur J Vasc Endovasc Surg. 2012;43:55-61. DOI: 10.1161/JAHA.118.009724.

article thumbnail

AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System

DAIC

This is the world’s first AI that can detect life-threatening cardiac conditions, including heart attacks, using a reduced leadset. KAI 12L can seamlessly integrate with compatible devices, including the Kardia 12L ECG System, expanding critical access to accurate heart data within a broad range of healthcare settings.

article thumbnail

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

DAIC

The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia.

article thumbnail

Shockwave Medical Expands U.S. Peripheral IVL Portfolio with Enhanced Catheter

DAIC

The Shockwave E 8 catheter is designed to optimize the treatment of patients with calcified femoro-popliteal and below-the-knee peripheral artery disease (PAD), including patients with complex chronic limb-threatening ischemia (CLTI). PAD affects more than eight million people aged 40 and older in the United States.

article thumbnail

Image Analysis Software for Cardiovascular Disease Assessment Gets 510(k) FDA Clearance

DAIC

With its basis in histology, the software is uniquely able to non-invasively quantify and characterize non-calcified plaque and its components such as lipid-rich necrotic core (LRNC), giving potential insights into high-risk plaques that are key drivers of risk of heart attack and stroke. Cardiovasc. 6 (3) (2019).

article thumbnail

The MI Overdiagnosis Problem

CardiacWire

The authors believe that the current MI diagnosis criteria (symptoms of coronary ischemia + abnormal troponin levels) isn’t sufficient, and the liberal use of troponin testing (particularly in the US) has compounded this problem. myocarditis) for one-fifth of the participants. So what’s causing this trend towards MI overdiagnosis?

article thumbnail

What do heart tests tell us?

Dr. Sanjay Gupta

So cardiomyopathies, valve problems, myocarditis and previous heart attacks all cause a problem with the pumping function of the heart. Patients with a completely normal CT scan are very unlikely to have a heart attack within the next 3-5 years. It is still possible to have ischemia without coronary disease.